Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Further Reading from MarketBeat 3 Blue-Chip Stocks Built for a Rotating MarketAuthor: Chris Markoch. Article Posted: 3/8/2026. 
Key Takeaways - Sector rotation in 2026 is favoring defensive, value-oriented areas such as utilities, healthcare, and consumer staples over mega-cap technology.
- Duke Energy and Gilead Sciences combine defensive characteristics with identifiable growth catalysts and reliable dividends.
- Hershey has rallied sharply with consumer staples, but its valuation now looks stretched relative to its earnings profile.
Sector rotation occurs when investors move money out of sectors that look overbought and into ones that appear undervalued. In 2026, that has generally meant a shift away from mega-cap technology names and toward value-oriented, defensive sectors such as energy and consumer staples. The key issue is valuation. Big tech has been running hot for more than two years, driven largely by enthusiasm for artificial intelligence (AI). Despite concerns about a repeat of the dot-com bubble, many investors largely ignored lofty valuations—until valuation started to matter again. As the economy shows signs of heating up, investors are seeking value elsewhere, including in blue-chip defensive names like the stocks listed here. Utilities Provide Stability in a Rotating Market Duke Energy (NYSE: DUK) is a logical beneficiary of sector rotation. Duke is a major utility provider in the Southeast and Midwest United States. Utilities stocks are typically defensive, viewed as value and income plays. Duke offers an attractive, secure dividend that yields around 3.2% and has raised its payout for 20 consecutive years. The evolving U.S. energy landscape is also creating growth opportunities for DUK. Duke follows an "all of the above" approach to power generation, including nuclear, hydroelectric and natural gas. Natural gas has helped drive the stock's strong bounce in 2026, but the company's stable residential utility revenue base and projected growth in areas such as data centers are what make DUK an attractive sector-rotation target. DUK is up nearly 12% in 2026, putting it within about 5% of its consensus price target of $136.87, which would push the stock above its 52-week high. Trading at roughly 20.5x earnings, the shares sit at a slight premium to their historical average. Since Duke reported earnings in February, analysts have been raising price targets amid expectations of strong year-over-year revenue growth in the second half of the year—sentiment that could prompt a bullish re-rating. Biotech Strength Gives Gilead Defensive Growth Some analysts see biotechnology as another beneficiary of the current rotation. Gilead Sciences (NASDAQ: GILD) offers defensive growth within healthcare, a sector that has lagged the broader market. Gilead is a leader in HIV therapies, with key drugs protected by patents into the 2030s. Investors are also encouraged by a pipeline of more than 50 candidates. Beyond HIV, the company expects to launch anito-cel, a CAR-T therapy for multiple myeloma, in 2026 and may see a label expansion for its breast cancer drug Trodelvy. GILD is up nearly 18% in 2026, a run that pushed the stock to a 52-week high. It has eased back slightly since, likely reflecting some profit-taking—pullbacks that may present a buy-the-dip opportunity. Analysts carry a consensus price target of $156.72 on GILD, implying upside of over 8%. Since Gilead's February earnings report, many analysts have raised their targets, with the most bullish estimates around $170. Gilead also pays a dependable dividend with a yield near 2.28% and has increased its payout for 10 consecutive years. Consumer Staples Rally Lifts Hershey Stock The Hershey Company (NYSE: HSY) has been one of the biggest beneficiaries of the rotation into consumer staples in 2026. HSY is up nearly 25% this year and has broken out of the bearish trend it faced since 2023. Hershey struggled with higher cocoa prices through 2025, and those costs will continue to weigh on earnings into 2026. Still, the market looks forward, and analysts are forecasting stronger earnings and revenue growth for the year. HSY is trading above its consensus price target of $222.21, but analysts have been lifting targets since the company's February earnings report. Goldman Sachs, the most bullish, has a $267 target. In that report, Hershey raised its dividend by 5.9%, marking 15 consecutive years of increases. The stock yields roughly 2.5% with an annual payout per share of $5.81. Following the recent run-up, HSY trades at more than 50x earnings—a valuation that likely prompted heavy institutional selling last quarter but could also give investors a chance to buy on any further pullbacks.
| 
